Back
Viking Therapeutics Stock Predictions
Sponsored
VKTX
Sponsored
The 7 new tech giants dominating today's markets
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.
Sell
28
VKTX
Viking Therapeutics
Last Price:
38.24
Seasonality Move:
40.87%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereViking Therapeutics Stock Forecast
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 87.7% based on the past 9 years of stock performance.
- Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
-
Is Viking Therapeutics Stock Undervalued?
The current Viking Therapeutics [VKTX] share price is $38.28. The Score for VKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal. - VKTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Viking Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Viking Therapeutics has on average historically risen by 87.7% based on the past 9 years of stock performance.
Viking Therapeutics Stock Rating
Sell
28
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics overpriced?
- Viking Therapeutics has risen higher in 4 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 44.44%
Viking Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vikingtherapeutics.com
52-Week Data
52-Week High:
99.41
52-Week Low:
17.23
Prediction Charts
Market Cap:
4.27B
Price in USD:
38.28
Volume:
12.92M
Beta:
1.24
Technical Analysis
SMA50:
58.67
SMA100:
59.69
SMA200:
62.24
52-Wk Change:
99.69%
Stock Predictions
-
Is Viking Therapeutics stock public?
Yes, Viking Therapeutics is a publicly traded company. -
What is the Viking Therapeutics stock quote today?
The Viking Therapeutics stock price is 38.28 USD today. -
How to buy Viking Therapeutics stock online?
You can buy Viking Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-29 | 54.10 | 52.94 | 54.54 | 52.80 |
Dec-2 | 52.40 | 51.51 | 52.81 | 51.24 |
Dec-3 | 51.00 | 50.26 | 51.50 | 49.06 |
Dec-4 | 50.68 | 51.24 | 51.49 | 49.50 |
Dec-5 | 50.87 | 49.88 | 52.58 | 49.76 |
Dec-6 | 50.23 | 50.80 | 51.92 | 49.87 |
Dec-9 | 50.87 | 50.35 | 51.68 | 49.90 |
Dec-10 | 50.10 | 47.85 | 50.60 | 47.50 |
Dec-11 | 48.19 | 49.21 | 49.47 | 47.55 |
Dec-12 | 49.00 | 47.87 | 49.67 | 47.63 |
Dec-13 | 47.99 | 47.03 | 48.13 | 45.93 |
Dec-16 | 47.06 | 47.23 | 48.55 | 46.68 |
Dec-17 | 46.09 | 46.70 | 47.87 | 46.09 |
Dec-18 | 43.09 | 38.28 | 43.55 | 37.80 |
Viking Therapeutics Earnings
Viking Therapeutics Earnings Report: Per Share Viking Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viking Therapeutics Forecast Revenue Growth
Viking Therapeutics Stock Analysis: Historical quarterly revenues per share for Viking Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.47 per share.
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.